Merck Says US CDC Committee Recommends Enflonsia in Infants As RSV Preventive Option-March 2024-www.financetom.com

Merck Says US CDC Committee Recommends Enflonsia in Infants As RSV Preventive Option

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Merck Says US CDC Committee Recommends Enflonsia in Infants As RSV Preventive Option

Jun 26, 2025 11:54 AM

02:37 PM EDT, 06/26/2025 (MT Newswires) -- Merck ( MRK ) said Thursday the US Centers for Disease Control and Prevention's committee recommended Enflonsia as a preventive option for respiratory syncytial virus lower respiratory tract disease in infants aged under 8 months.

The CDC's Advisory Committee on Immunization Practices also voted to include Enflonsia in the Vaccines for Children program, aimed at improving access for eligible infants, the company said.

Enflonsia is a long-acting monoclonal antibody designed to offer direct protection throughout a typical five-month respiratory syncytial virus season with a single weight-independent dose, it added.

The company said it expects to begin shipping the product ahead of the 2025-2026 RSV season, with availability for ordering starting in July.

The recommendation is provisional and will take effect once approved by the CDC Director or the Health and Human Services Secretary, according to the company.

Price: 79.22, Change: -0.45, Percent Change: -0.56

Previous page： Tenet Healthcare Insider Sold Shares Worth $2,926,800, According to a Recent SEC Filing Next page： Analysis-Foreign airlines lose interest in China as domestic carriers expand abroad

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Tenet Healthcare Insider Sold Shares Worth $2,926,800, According to a Recent SEC Filing

Aug 9, 2024

03:10 AM EDT, 08/09/2024 (MT Newswires) -- Meghan Fitzgerald, Director, on August 06, 2024, sold 20,000 shares in Tenet Healthcare ( THC ) for $2,926,800. Following the Form 4 filing with the SEC, Fitzgerald has control over a total of 15,269 shares of the company, with 15,269 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/70318/000095017024094286/xslF345X03/ownership.xml Price: 150.99, Change: +0.89, Percent Change: +0.59...

Analysis-Foreign airlines lose interest in China as domestic carriers expand abroad

Aug 9, 2024

SEOUL (Reuters) - Chinese airlines are gaining market share on international routes, industry data shows, as foreign rivals are deterred by weak China travel demand and rising costs and extended flight times because of the need to avoid Russian airspace. Foreign airlines, led by Western carriers such as British Airways and Australia's Qantas Airways ( QUBSF ), are pulling services...

Snap Insider Sold Shares Worth $1,327,380, According to a Recent SEC Filing

Aug 9, 2024

03:09 AM EDT, 08/09/2024 (MT Newswires) -- Evan Spiegel, 10% Owner, Director, Chief Executive Officer, on August 06, 2024, sold 150,000 shares in Snap (SNAP) for $1,327,380. Following the Form 4 filing with the SEC, Spiegel has control over a total of 39,213,540 shares of the company, with 35,885,696 shares held directly and 3,327,844 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1564408/000095017024094297/xslF345X03/ownership.xml Price:...

Snap Insider Sold Shares Worth $8,688,800, According to a Recent SEC Filing

Aug 9, 2024

03:10 AM EDT, 08/09/2024 (MT Newswires) -- Robert C. Murphy, 10% Owner, Director, Chief Technology Officer, on August 06, 2024, sold 1,000,000 shares in Snap (SNAP) for $8,688,800. Following the Form 4 filing with the SEC, Murphy has control over a total of 68,861,339 shares of the company, with 58,553,813 shares held directly and 10,307,526 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1564408/000095017024094298/xslF345X03/ownership.xml...